Author:
Woodbury Michael J.,Smith Katherine Nabel,Smith Jeffrey S.,Merola Joseph F.
Funder
National Institute of General Medical Sciences
Reference10 articles.
1. A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients [published correction appears in Front Immunol. 2022 Nov 25;13:1094578];Eugster;Front Immunol,2022
2. Role of anifrolumab in refractory cutaneous manifestations of lupus erythematosus: a case series and literature review;Khan;Cureus,2023
3. Treatment with anifrolumab for discoid lupus erythematosus;Trentin;JAMA Dermatol,2023
4. Successful treatment of severe chronic cutaneous lupus with anifrolumab: a series of 6 cases;Kowalski;JAAD Case Rep,2023
5. Alopecia secondary to severe discoid lupus responding to anifrolumab;Han;Int J Womens Dermatol,2023